FP
Fred M Powell
Executive Vice President & CFO

Fred M Powell insider trades: Antares Pharma (ATRS) stock purchases

Executive Vice President & CFO, Antares Pharma Last trade Nov 12, 2020 39 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2008
6
Companies
last trade 2020

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Fred reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 12, 2020ATRS↑ Buy$47K
Jun 9, 2017ATRS↑ Buy$363K
Dec 9, 2016ATRS↑ Buy$203K
Oct 5, 2015CPXX↑ Buy$24K
Nov 18, 2014CPXX↑ Buy$13K
May 15, 2014CPXX↑ Buy$6K
Dec 17, 2013CPXX↑ Buy$9K
Aug 13, 2009BJGP↑ Buy$4K
May 22, 2008BJGP↑ Buy$10K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Fred M Powell's insider trades

Fred M Powell is Executive Vice President & CFO at Antares Pharma (ATRS). Since May 22, 2008, Fred has reported 9 open-market purchases worth $679K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (20 filings), shares withheld for taxes (12 filings), shares returned to the company (4 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ATRS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.